BUSINESS

• Astellas, Mitsubishi Tanabe to Share Compound Libraries
  March 30, 2016

• In a Setback, FDA Rebuffs Label Expansion for Takeda’s Brintellix
  March 30, 2016

• PeptiDream, Asahi Kasei Pharma Forge Research Collaboration
  March 29, 2016

• Mylan Japan Offers Severance Package for 110 Sales Reps
  March 29, 2016

• ASKA Shoots for Group Annual Sales of 70 Billion Yen in Five Years
  March 29, 2016

• Asian PII Study Launched for Solasia’s PTCL Treatment: Meiji Seika Pharma
  March 29, 2016

• Torii Looks to Ramp Up Sales in Allergen Sector, Expand Indications for Sublingual Therapies
  March 28, 2016

• IP High Court Rules in Favor of Chugai in Oxarol Patent Suit
  March 28, 2016

• Lilly Joins Hands with NCC on Biomarkers for Advanced Gastric Cancer
  March 28, 2016

• Global PIII for Xtandi Launched for Hormone Sensitive Prostate Cancer: Astellas
  March 28, 2016

• Takashi Nakamura to Be Promoted to President of Qol
  March 25, 2016

• Public Knowledge-Based Application Filed for Colchicine for Familial Mediterranean Fever
  March 25, 2016

• MSD Going Full Out for Sakigake-Designated Pembrolizumab, Poised to Bolster Oncology Force
  March 25, 2016

• Lilly Japan Logs 236 Billion Yen in 2015, Set to Further Boost Sales Force from 2,000
  March 25, 2016

• Sosei Group Taps GSK Veteran Peter Bains as Next CEO
  March 24, 2016

• Eisai Withdraws Japan NDA for Ultra-High Dose Mecobalamin for ALS
  March 24, 2016

• Hengrui to Apply for Sakigake Designation; Develop New Drugs Alongside Generics in Japan
  March 24, 2016

• Eisai to Return US Rights to Helsinn’s Antiemetic Akynzeo
  March 23, 2016

• Valixa Filed for Prevention of CMV Disease in Organ Transplants: Mitsubishi Tanabe
  March 23, 2016

• Romosozumab Yields Positive PIII Data in Male Osteoporosis: Amgen Astellas
  March 23, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 477
• 478
• 479
• 480
• 481
• 482
• 483
• 484
• 485
• …
• Next ›
• 最終 »